Secondary hemophagocytic syndrome in adults: A case series of 18 patients in a single institution and a review of literature

Hematological Oncology

Volumn 29, Issue 2, 2011, Pages 100-106

  Shabbir, Munira ^a   Lucas, John ^b   Lazarchick, John ^b   Shirai, Keisuke ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adult; Hemophagocytic syndrome; Outcome; Secondary

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CYTOPENIA; DYSFIBRINOGENEMIA; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERTRANSAMINASEMIA; HYPERTRIGLYCERIDEMIA; IDIOPATHIC DISEASE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER TRANSPLANTATION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC DISEASE; SICKLE CELL ANEMIA; SPLENOMEGALY; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA, SICKLE CELL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; STEM CELL TRANSPLANTATION; SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959258419     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.960     Document Type: Article

References (45)

1. Janka GE. Hemophagocytic syndromes. Blood Rev 2007; 21(5): 245-253.
2. Szyper-Kravitz M. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. Isr Med Assoc J 2009; 11(10): 633-634.
3. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program 2009; (1): 127-131.
4. Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 1993; 15(1): 92-98.
5. Bell RJ, Brafield AJ, Barnes ND, France NE. Familial haemophagocytic reticulosis. Arch Dis Child 1968; 43(231): 601-606.
6. Allen M, De Fusco C, Legrand F. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica 2001; 86(5): 499-503.
7. Henter JI, Elinder G, Söder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991; 80(4): 428-435.
8. Aricò M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996; 10(2): 197-203.
9. Phillips J, Staszewski H, Garrison M. Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis. Hematology 2008; 13(5): 282-285.
10. Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 2003; 41(2): 103-109.
11. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6(6): 601-608.
12. Celkan T, Berrak S, Kazanci E, et al. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey. Turk J Pediatr 2009; 51(3): 207-213.
13. Cortis E, Insalaco A. Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr Suppl 2006; 95(452): 38-41.
14. Parodi A, Davì S, Pringe AB, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009; 60(11): 3388-3399.
15. Finkielman JD, Grinberg AR, Paz LA, et al. Case report: reactive hemophagocytic syndrome associated with disseminated strongyloidiasis. Am J Med Sci 1996; 312(1): 37-39.
16. Brown RE, Bowman WP, D'Cruz CA, et al. Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacin. Cancer 1987; 60(10): 2388-2393.
17. Perez N, Virelizier JL, Arenzana-Seisdedos F, Fischer A, Griscelli C. Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr 1984; 104(4): 569-573.
18. Eife R, Janka GE, Belohradsky BH, Holtmann H. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 1989; 6(3): 265-272.
19. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program 2005; (1): 82-88.
20. Aricò M, Nespoli L, Maccario R, et al. Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child 1988; 63(3): 292-296.
21. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286(5446): 1957-1959.
22. Katano H, Cohen JI. Perforin and lymphohistiocytic proliferative disorders. Br J Haematol 2005; 128(6): 739-750.
23. Feldmann J, Callebaut I, Raposo G, et al. Munc 13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003; 115(4): 461-473.
24. Bryceson YT, Rudd E, Zheng C, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007; 110(6): 1906-1915.
25. Nagle DL, Karim MA, Woolf EA, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996; 14(3): 307-311.
26. Ménasché G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000; 25(2): 173-176.
27. Enders A, Zieger B, Schwarz K, et al. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 2006; 108(1): 81-87.
28. Tabata Y, Villanueva J, Lee SM, et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 2005; 105(8): 3066-3071.
29. Arico M, Imashuku S, Clementi R, et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood 2001; 97(4): 1131-1133.
30. Marsh RA, Villanueva J, Zhang K, et al. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytometry B Clin Cytom 2009; 76(5): 334-344.
31. Hazen MM, Woodward AL, Hofmann I, et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum 2008; 58(2): 567-570.
32. Vastert SJ, van Wijk R, D'Urbano LE, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49(3): 441-449.
33. Clementi R, Locatelli F, Dupré L, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood 2005; 105(11): 4424-4428.
34. Ramanan AV, Schneider R. Macrophage activation syndrome-what's in a name. J Rheumatol 2003; 30(12): 2513-2516.
35. Komp DM, McNamara J, Buckley P. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 1989; 73(8): 2128-2132.
36. Moestrup SK, Moller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004; 36(5): 347-354.
37. Schaer DJ, Schleiffenbaum B, Kurrer M, et al. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol 2005; 74(1): 6-10.
38. Henter JI, Aricò M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997; 28(5): 342-347.
39. You CR, Kim HR, Yoon CH, Lee SH, Park SH, Kim HY. Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report. J Korean Med Sci 2006; 21(6): 1124-1127.
40. Henzan T, Nagafuji K, Tsukamoto H, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 2006; 81(1): 59-61.
41. Kaza U, Knight AK, Jeroudi M, Bocchini JA Jr, Anga A, Bahna SL. A boy with fever, lymphadenopathy, hepatosplenomegaly, and lymphocytosis. Allergy Asthma Proc 2008; 29(2): 216-220.
42. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2007; 29(8): 569-573.
43. Olin RL, Nichols KE, Naghashpour M, et al. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol 2008; 83(9): 747-749.
44. Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100(7): 2367-2373.
45. Yoon HS, Im HJ, Moon HN, et al. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis. Pediatr Transplant 2010, DOI: 10.1111/j.1399-3046.2009.01284.x